Skip to main content

Table 6 Mean values of ICS score of gender, age groups, cancer, breast cancer, colorectal cancer and healthy controls

From: Reliability and validity of a new scale on internal coherence (ICS) of cancer patients

 

Internal Coherence Scale

Inner Resilience and Coherence

Thermo Coherence

Self regulation

STUDY 1

    

Gender

    

Female (71.9%)

36.52 (7.82)

28.67 (6.44)

7.91 (1.53)

4.05 (0.80)

Male (28.1%)

38.84 (7.17)

30.32 (5.91)

7.94 (1.46)

4.25 (0.65)

Individuals

    

Healthy controls (SD)

40.12 (5.12)

31.43 (4.48)

8.25 (1.30)

4.27 (0.72)

Cancer (SD)

34.23 (8.68)

26.80 (7.07)

7.60 (1.64)

3.97 (0.78)

p-value *

<0.001

<0.001

0.028

0.079

STUDY 2

    

Breast cancer group 1 T0

36.12 (7.64)

28.41 (6.54)

7.70 (2.28)

 

Breast cancer group 1 T1

34.88 (7.53)

27.29 (6.25)

7.58 (1.97)

 

Breast cancer group 1 T2

35.35 (6.38)

27.94 (5.99)

7.41 (1.97)

 

Colorectal cancer T0

38.87 (6.49)

30.43 (5.81)

8.30 (1.94)

 

Colorectal cancer T1

35.88 (9.36)

28.47 (7.79)

7.12 (2.33)

 

Colorectal cancer T2

38.96 (6.75)

32.04 (5.44)

7.48 (2.27)

 

p-value T0 vs T1 **

0.026

0.043

0.020

 

p-value T1 vs T2**

0.009

0.008

0.268

 
  1. * Exact U-Test (2-side), ** Exact Wilcoxon-Test (1-side) used for pooled breast cancer and colorectal cancer and tests T0 (before chemotherapy) vs. T1 (1–5 days after third chemotherapy cycle) and T1 vs. T2 (4 – 8 weeks after the end of chemotherapy).
  2. Significant differences (p < 0.05) are presented bold.